CC
HZNP

Clearline Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Clearline Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-35,000
Closed -$415K – 61
2017
Q2 		$415K Hold
35,000
– – 0.26% 40
2017
Q1 		$517K Hold
35,000
– – 0.24% 50
2016
Q4 		$566K Buy
+35,000
New +$566K 0.26% 41